L-Arginine



Compound IDCDAMM00045
Common nameL-Arginine
IUPAC name(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid
Molecular formulaC6H14N4O2

Experimental data

Retention time5.71
Adduct[M+H]+
Actual mz175.119
Theoretical mz175.119
Error1.43
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score9.136

Identifiers and class information

Inchi keyODKSFYDXXFIFQN-BYPYZUCNSA-N
SmilesC(CC(C(=O)O)N)CN=C(N)N
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)1
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)174.202
Computed dipole moment(dipole)7.345
Total solvent accessible surface area (SASA)415.466
Hydrophobic component of SASA (FOSA)119.44
Hydrophilic component of SASA (FISA)296.026
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)641.288
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)5
Free energy of solvation of dipole (dip^2/V)0.0841301
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0318408
Globularity descriptor (glob)0.865629
Predicted polarizability in cubic angstroms (QPpolrz)15.016
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.596
Predicted octanol/gas partition coefficient (QPlogPoct)18.832
Predicted water/gas partition coefficient (QPlogPw)16.366
Predicted octanol/water partition coefficient (QPlogPo/w)-3.577
Predicted aqueous solubility (QPlogS)-0.149
Conformation-independent predicted aqueous solubility (CIQPlogS)0.174
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.625
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.975
Predicted brain/blood partition coefficient (QPlogBB)-2.094
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.388
Predicted skin permeability, log Kp (QPlogKp)-10.428
PM3 calculated ionization potential (IP(ev))8.028
PM3 calculated electron affinity (EA(eV))-1.282
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.229
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)144.968
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29475NOS1Nitric-oxide synthase, brainT16117SEA
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
P29474NOS3Nitric-oxide synthase, endothelialT06046SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P08514ITGA2BIntegrin alpha-IIb/beta-3T50688SEA
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
Q9H4A4RNPEPAminopeptidase BT57818SEA
P04229HLA-DRB1HLA class II histocompatibility antigen DRB1-1T83611SEA
Q01726MC1RMelanocortin receptor 1T35842SEA
Q16581C3AR1C3a anaphylatoxin chemotactic receptorT30219SEA
P25116F2RProteinase-activated receptor 1T36483SEA
P05089ARG1Arginase-1 (by homology)T63224SEA
Q04756HGFACHepatocyte growth factor activatorT38584SEA
P15169CPN1Carboxypeptidase N, catalytic subunitT34471SEA
Q15109AGERAdvanced glycosylation end product receptorT07400SEA
P09958FURHUMAN dibasic-processing enzymeT98945SEA
P17342NPR3Natriuretic peptide receptorT92963SEA
P16066NPR1Atrial natriuretic peptide receptor AT71230SEA
P05106ITGB3Integrin beta-3T26457SEA
P00480OTCOrnithine transcarbamylaseT52098SEA
Q16348PEPT2Solute carrier family 15 member 2T52067SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16117DI0173Headache[ICD-11: 8A80-8A84]P29475NOS1
T16117DI0264Migraine[ICD-11: 8A80]P29475NOS1
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T06046DI0287Myocardial infarction[ICD-11: BA41-BA43]P29474NOS3
T50688DI0007Acquired hypermelanosis[ICD-11: ED60]P08514ITGA2B
T50688DI0030Angina pectoris[ICD-11: BA40]P08514ITGA2B
T50688DI0287Myocardial infarction[ICD-11: BA41-BA43]P08514ITGA2B
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T83611DI0275Multiple sclerosis[ICD-11: 8A40]P04229HLA-DRB1
T35842DI0192Hypoactive sexual desire dysfunction[ICD-11: HA00]Q01726MC1R
T35842DI0205Inborn porphyrin/heme metabolism error[ICD-11: 5C58]Q01726MC1R
T36483DI0287Myocardial infarction[ICD-11: BA41-BA43]P25116F2R
T63224DI0258Metabolism inborn error[ICD-11: 5C50]P05089ARG1
T07400DI0025Alzheimer disease[ICD-11: 8A20]Q15109AGER
T07400DI0083Chronic kidney disease[ICD-11: GB61]Q15109AGER
T07400DI0115Dementia[ICD-11: 6D80-6D8Z]Q15109AGER
T07400DI0196Hypotension[ICD-11: BA20-BA21]Q15109AGER
T98945DI0263Middle East Respiratory Syndrome[ICD-11: 1D64]P09958FUR
T92963DI0175Heart failure[ICD-11: BD10-BD1Z]P17342NPR3
T71230DI0175Heart failure[ICD-11: BD10-BD1Z]P16066NPR1
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC

Copyright © 2025